SCHEMBL10280335

SCHEMBL10280335

Bc1ccc(O)c(P)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12667819 0.75 — —
SCHEMBL20153036 0.72 CNR2 (0.39) —
SCHEMBL10793095 0.72 — —
Bromide SCHEMBL4584444 0.70 ALOX5 (0.44) —
Bromide SCHEMBL28524370 0.70 ALOX5 (0.44) —
Water SCHEMBL9053915 0.70 ALOX5 (0.44) —
SCHEMBL1755271 0.70 — —
SCHEMBL14149244 0.68 — —
SCHEMBL22284780 0.68 — —
SCHEMBL22284791 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2102169-B1 INDAZOLYL AMIDE DERIVATIVES FOR THE TREATMENT OF GLUCOCORTICOID RECEPTOR MEDIATED DISORDERS ASTRAZENECA AB (SE) 2012-06-20 — — EP disclosed
Send feedback